Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Emsella for Reducing tSUI After HOLEP

NCT: NCT07580404 · ENROLLING_BY_INVITATION

NCT IDNCT07580404
StatusENROLLING_BY_INVITATION
Start Date2026-07-24
SponsorNorthwestern University (OTHER)
First posted
Last updated

Brief Summary

This study aims to investigate the effectiveness of the Emsella chair treatments at different timepoints. Before and after the holmium laser enucleation of the prostate (HoLEP).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑